Notable Healthcare Headlines for the Week: UnitedHealth, Eli Lilly, J&J in Focus
Insiders At Abbott Laboratories Sold US$3.3m In Stock, Alluding To Potential Weakness
10 Health Care Stocks Whale Activity In Today's Session
Catalyst Watch: Spotlight on Tesla, Alphabet Earnings, AACR Drug Data, and Global PMI Reports
A Quick Look at Today's Ratings for Abbott Laboratories(ABT.US), With a Forecast Between $140 to $155
The Abbott Laboratories (NYSE:ABT) First-Quarter Results Are Out And Analysts Have Published New Forecasts
Abbott Laboratories' Earnings Call Highlights Robust Growth
RBC Capital Maintains Outperform on Abbott Laboratories, Raises Price Target to $145
Abbott Labs Is Maintained at Overweight by Wells Fargo
Abbott Labs Is Maintained at Overweight by Barclays
These Analysts Boost Their Forecasts On Abbott Laboratories After Better-Than-Expected Earnings
Demystifying Abbott Laboratories: Insights From 11 Analyst Reviews
Abbott Labs Is Maintained at Buy by Stifel
A Quick Look at Today's Ratings for Abbott Laboratories(ABT.US), With a Forecast Between $130 to $159
Jefferies Adjusts Price Target on Abbott Laboratories to $137 From $135, Keeps Hold Rating
Abbott Laboratories Analyst Ratings
TD Cowen Adjusts Price Target on Abbott Laboratories to $145 From $135, Keeps Buy Rating
BTIG Adjusts Price Target on Abbott Laboratories to $145 From $140, Keeps Buy Rating
Express News | Abbott Laboratories : Oppenheimer Raises Target Price to $140 From $134
Today's Analyst Rating | Morgan Stanley Cuts Its Price Target Cut on Microsoft to $472, Piper Sandler Cuts Its Price Target Cut on NVIDIA to $150